patient

Zacks Small Cap Research – MGRM: The De-Risking of the Monogram Story from FDA Clearance and Initiation of Live Patient Trials Supports Price Target of $6.00 – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 1st quarter 2025 financial results on May 14, 2025 which were largely in line with our expectations. Research and development expenses for the quarter were $2.26 million compared to $2.41 million in the prior year period. The R&D decrease was primarily … Read more

Kaiser Permanente in Hawaii Cures 1,000th Patient With Hepatitis C – Go Health Pro

by
Kaiser Permanente in Hawaii Cures 1,000th Patient With Hepatitis C – Go Health Pro

When Dr. Collis joined the Hawaii Permanente Medical Group in 2001, he saw an opportunity to leverage resources to fight hepatitis C. The clinic was founded in 2004 with a modest budget and quickly doubled the cure rates of patients within Kaiser Permanente in Hawaii. The approval of direct-acting medications such as Harvoni in late … Read more

Hackers publish sensitive patient data allegedly stolen from Australian IVF provider Genea – Go Health Pro

by
Hackers publish sensitive patient data allegedly stolen from Australian IVF provider Genea – Go Health Pro

Hackers claim to have published a trove of sensitive data belonging to IVF patients after a cyberattack on Genea, one of Australia’s largest fertility providers.  Genea said last week that it had experienced a cybersecurity incident that led to sensitive patient information potentially being compromised. In a statement given to TechCrunch on Wednesday, Genea CEO … Read more

Zacks Small Cap Research – AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier – Go Health Pro

by
Zacks Small Cap Research – AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier – Go Health Pro

By M. Marin NASDAQ:AEMD Aethlon Medical (NASDAQ:AEMD) announced that the first patient in its Australian safety, feasibility and dose-finding clinical trial has been treated with the Hemopurifier. The trial is designed for patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment. In other words, the trial is evaluating the Hemopurifier … Read more

CISA and FDA Warn of Critical Backdoor in Contec CMS8000 Patient Monitors – Go Health Pro

by
CISA and FDA Warn of Critical Backdoor in Contec CMS8000 Patient Monitors – Go Health Pro

Jan 31, 2025Ravie LakshmananVulnerability / Healthcare The U.S. Cybersecurity and Infrastructure Security Agency (CISA) and the Food and Drug Administration (FDA) have issued alerts about the presence of hidden functionality in Contec CMS8000 patient monitors and Epsimed MN-120 patient monitors. The vulnerability, tracked as CVE-2025-0626, carries a CVSS v4 score of 7.7 on a scale … Read more